Frazer A Tessema
Overview
Explore the profile of Frazer A Tessema including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Lalani H, Tessema F, Kesselheim A, Rome B
J Gen Intern Med
. 2024 Feb;
39(12):2187-2195.
PMID: 38321315
Background: Direct-to-consumer (DTC) pharmacies sell generic prescription drugs, often at lower prices than traditional retail pharmacies; however, not all drugs are available, and prices vary. Objective: To determine the availability...
3.
Cliff E, Kelkar A, Russler-Germain D, Tessema F, Raymakers A, Feldman W, et al.
Am Soc Clin Oncol Educ Book
. 2023 Jul;
43:e397912.
PMID: 37433102
Chimeric antigen receptor (CAR) T-cells are a cellular immunotherapy with remarkable efficacy in treating multiple hematologic malignancies but they are associated with extremely high prices that are, for many countries,...
4.
Tessema F, Barenie R, Avorn J, Kesselheim A
Health Aff (Millwood)
. 2023 May;
42(5):642-649.
PMID: 37126755
In July 2012, tenofovir disoproxil fumarate-emtricitabine (TDF-FTC, brand name Truvada) was approved by the Food and Drug Administration (FDA) to prevent HIV infection. To estimate the extent of the US...
5.
Tessema F, Sarpatwari A, Rand L, Kesselheim A
J Law Med Ethics
. 2022 Jul;
50(2):380-384.
PMID: 35894560
Gene therapies to treat sickle cell disease are in development and are expected to have high costs. The large eligible population size - by far, the largest for a gene...
6.
Tessema F, Lapping-Carr G, Affini M, Selkridge I, Oppong A, Jones T, et al.
Trauma Surg Acute Care Open
. 2022 Jun;
7(1):e000955.
PMID: 35719190
Sickle cell trait (SCT) has historically been considered a benign condition, but SCT-positive patients have increased baseline risk of venous thromboembolism and chronic kidney disease, as well as increased risk...
7.
Sarpatwari A, Tessema F, Zakarian M, Najafzadeh M, Kesselheim A
Health Aff (Millwood)
. 2021 May;
40(5):772-778.
PMID: 33939506
List prices for brand-name drugs have risen steeply, often despite the introduction of competition from other brand-name drugs in the same therapeutic class. List prices, however, do not reflect any...
8.
Beall R, Quinn A, Kesselheim A, Tessema F, Sarpatwari A
J Law Med Ethics
. 2021 Jan;
48(4):789-795.
PMID: 33404340
No abstract available.
9.
Sarpatwari A, He M, Tessema F, Gagne J, Kesselheim A
Drug Saf
. 2020 Nov;
44(3):327-335.
PMID: 33206339
Introduction: Risk evaluation and mitigation strategy (REMS) programs are intended to improve safe use of US Food and Drug Administration-approved drugs. However, controversy exists over whether they consistently accomplish this...
10.
Barenie R, Avorn J, Tessema F, Kesselheim A
Drug Discov Today
. 2020 Oct;
26(1):273-281.
PMID: 33011345
The approval of sofosbuvir (Sovaldi) in 2013 transformed chronic hepatitis C virus (HCV) care, but its high cost was criticized in part because of reports of substantial public involvement in...